Legal

Terms of Use

Last updated: September 21, 2026

SummaryThe linked document on dosys.health governs.

The authoritative Terms of Use for Vancomyzer™ is maintained at dosys.health/legal/terms. The summary below is provided for reference; the linked document governs in case of any conflict.

Subscriptions, renewal and cancellation

Existing subscriptions and institutional agreements retain their agreed terms. Manage an existing subscription in Billing, or contact us about your agreement.

Cancel online through Settings, then Billing, then Manage billing / cancel. Administrators of existing institutional subscriptions use Team, then Manage billing. Cancel before the trial ends to avoid a charge, or before the next renewal to stop that charge. Cancellation stops future renewal; access continues through the remaining paid period unless otherwise stated in your agreement.

A confirmation email records your subscription and cancellation details. Renewal reminders include management links. We will provide required advance notice of accepted fee changes, including 7–30 days before a change takes effect where California law applies. The new public prices do not automatically change existing subscription agreements.

Existing institutional agreements retain their written scope. Team administration, audit logs, multi-site arrangements and any business associate agreement require separate written review. EHR integration is not included.

Acceptance of Terms

By accessing or using Vancomyzer™, you agree to be bound by these Terms of Use and the Medical Disclaimer. If you do not agree, do not use this tool.

Permitted Use

Vancomyzer™ is licensed to qualified healthcare professionals, and to institutions that subscribe on their behalf, for internal clinical, educational, and quality-improvement use. Subject to these Terms and payment of any applicable fees, you are granted a limited, non-exclusive, non-transferable, non-sublicensable license to access and use the tool for that purpose. Using it in the course of your practice or employment, including at a for-profit institution, is permitted.

You may not:

  • Resell, rent, sublicense, white-label, or otherwise make the tool available to anyone who is not an authorized user under your own subscription
  • Operate the tool as a service bureau or application service provider, or offer dosing services to third parties as a standalone product built on it
  • Modify, copy, reproduce, distribute, or create derivative works from this tool without prior written consent
  • Remove or alter any copyright, trademark, or legal notices
  • Reverse-engineer or attempt to extract proprietary algorithms or model parameters
  • Access the tool in order to design or develop a competing product

Intellectual Property

All content, design, algorithms, and code comprising Vancomyzer™ are the exclusive intellectual property of their respective owners. All rights reserved. The Vancomyzer™ name and logo are trademarks. Unauthorized use of any intellectual property associated with this tool is prohibited.

Clinical Responsibility

Users remain solely responsible for independent clinical review, institutional-policy alignment, and final treatment decisions. Do not rely on this tool as a substitute for professional judgment, local protocol, product labeling, or therapeutic drug monitoring.

Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE DEVELOPERS OF VANCOMYZER SHALL NOT BE LIABLE FOR ANY DAMAGES OF ANY KIND ARISING FROM USE OF THIS TOOL. SEE THE FULL MEDICAL DISCLAIMER FOR COMPLETE LIABILITY LANGUAGE.

Modifications

We may update these terms. Subscription changes remain subject to applicable notice and consent requirements; continued free use does not authorize paid billing.

Governing Law

These terms are governed by the laws of the State of Texas, without regard to its conflict-of-law rules. Any dispute arising from these terms or from use of Vancomyzer™ shall be brought in the state or federal courts located in Hidalgo County, Texas, and you consent to the jurisdiction of those courts.